1-3 of 3
Julia Huber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7469: Inflammation plays an important role in the progression of chronic myeloid leukemia

Free
Melanie Langhammer, Julia Schöpf, Timo Jaquet, Katharina Horn, Moritz Angel, Daniel Mohl, Simon Lagies, Corinna Spohr, Daniel Christen, Franziska Maria Uhl, Tiago Maié, Henrike Jacobi, Thorsten B. Feyerabend, Julia Huber, Marcus Panning, Cassian Sitaru, Ivan Costa, Robert Zeiser, Konrad Aumann, Heiko Becker, Till Braunschweig, Steffen Koschmieder, Bernd Kammerer, Khalid Shoumariyeh, Michael Huber, Mirle Schemionek-Reinders, Tilman Brummer, Sebastian Halbach
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7469.
https://doi.org/10.1158/1538-7445.AM2024-7469
Published: 22 March 2024
View articletitled, Abstract 7469: Inflammation plays an important role in the progression of chronic myeloid leukemia
Journal Articles

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma

Open Access
Lenka Besse, Andrej Besse, Sara C. Stolze, Amin Sobh, Esther A. Zaal, Alwin J. van der Ham, Mario Ruiz, Santosh Phuyal, Lorina Büchler, Marc Sathianathan, Bogdan I. Florea, Jan Borén, Marcus Ståhlman, Julia Huber, Arnold Bolomsky, Heinz Ludwig, J. Thomas Hannich, Alex Loguinov, Bart Everts, Celia R. Berkers, Marc Pilon, Hesso Farhan, Christopher D. Vulpe, Herman S. Overkleeft, Christoph Driessen
Journal: Cancer Research
Cancer Res (2021) 81 (17): 4581–4593.
https://doi.org/10.1158/0008-5472.CAN-20-3323
Published: 01 September 2021
View articletitled, Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
Open the PDF for Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 5093: Bcr-Abl leads to mast cell differentiation and promotes degranulation of cells derived from a chronic myeloid leukemia mouse model in a Gab2 dependent manner

Free
Julia Ellermann, Franziska Maria Uhl, Martin Köhler, Julia Huber, Robert Zeiser, Steffen Koschmieder, Konrad Aumann, Tilman Brummer, Sebastian Halbach
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5093.
https://doi.org/10.1158/1538-7445.AM2018-5093
Published: 01 July 2018
View articletitled, Abstract 5093: Bcr-Abl leads to mast cell differentiation and promotes degranulation of cells derived from a chronic myeloid leukemia mouse model in a Gab2 dependent manner